Clinical trial / 2015
Green tea decreased prostate nuclear NFκB, systemic oxidation, and serum PSA before surgery.
In an open-label trial, 113 men with prostate cancer were randomized to consume six daily cups of brewed green tea, black tea, or water before radical prostatectomy; 93 finished the intervention. Proliferation, apoptosis, and tissue oxidation markers did not differ across groups. Green tea significantly decreased prostate tissue nuclear NFκB (p = 0.013), reduced urinary 8OHdG (p = 0.03), and modestly lowered serum PSA (p = 0.04) relative to control.
- Study type
- Randomized controlled trial
- Who was studied
- 113 men with prostate cancer awaiting radical prostatectomy
- What was measured
- Prostate tumor tissue biomarkers, urinary oxidation, and serum PSA
THE PAPER
Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ. Prostate, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.